Srinivasan V Narayanan1, Kunjan R Dave1, Isa Saul1, Miguel A Perez-Pinzon2. 1. From the Cerebral Vascular Disease Research Laboratories (S.V.N., K.R.D., I.S., M.A.P.-P.), Neuroscience Program (S.V.N., K.R.D., M.A.P.-P.), and Department of Neurology (S.V.N., K.R.D., I.S., M.A.P.-P.), University of Miami Miller School of Medicine, FL; and University of Miami Miller School of Medicine MD/PhD Program (S.V.N.). 2. From the Cerebral Vascular Disease Research Laboratories (S.V.N., K.R.D., I.S., M.A.P.-P.), Neuroscience Program (S.V.N., K.R.D., M.A.P.-P.), and Department of Neurology (S.V.N., K.R.D., I.S., M.A.P.-P.), University of Miami Miller School of Medicine, FL; and University of Miami Miller School of Medicine MD/PhD Program (S.V.N.). perezpinzon@miami.edu.
Abstract
BACKGROUND AND PURPOSE: Nuclear erythroid 2 related factor 2 (Nrf2) is an astrocyte-enriched transcription factor that has previously been shown to upregulate cellular antioxidant systems in response to ischemia. Although resveratrol preconditioning (RPC) has emerged as a potential neuroprotective therapy, the involvement of Nrf2 in RPC-induced neuroprotection and mitochondrial reactive oxygen species production after cerebral ischemia remains unclear. The goal of our study was to study the contribution of Nrf2 to RPC and its effects on mitochondrial function. METHODS: We used rodent astrocyte cultures and an in vivo stroke model with RPC. An Nrf2 DNA binding ELISA and protein analysis via Western blotting of downstream Nrf2 targets were performed to determine RPC-induced activation of Nrf2 in rat and mouse astrocytes. After RPC, mitochondrial function was determined by measuring reactive oxygen species production and mitochondrial respiration in both wild-type and Nrf2-/- mice. Infarct volume was measured to determine neuroprotection, whereas protein levels were measured by immunoblotting. RESULTS: We report that Nrf2 is activated by RPC in rodent astrocyte cultures, and that loss of Nrf2 reduced RPC-mediated neuroprotection in a mouse model of focal cerebral ischemia. In addition, we observed that wild-type and Nrf2-/- cortical mitochondria exhibited increased uncoupling and reactive oxygen species production after RPC treatments. Finally, Nrf2-/- astrocytes exhibited decreased mitochondrial antioxidant expression and were unable to upregulate cellular antioxidants after RPC treatment. CONCLUSIONS: Nrf2 contributes to RPC-induced neuroprotection through maintaining mitochondrial coupling and antioxidant protein expression.
BACKGROUND AND PURPOSE: Nuclear erythroid 2 related factor 2 (Nrf2) is an astrocyte-enriched transcription factor that has previously been shown to upregulate cellular antioxidant systems in response to ischemia. Although resveratrol preconditioning (RPC) has emerged as a potential neuroprotective therapy, the involvement of Nrf2 in RPC-induced neuroprotection and mitochondrial reactive oxygen species production after cerebral ischemia remains unclear. The goal of our study was to study the contribution of Nrf2 to RPC and its effects on mitochondrial function. METHODS: We used rodent astrocyte cultures and an in vivo stroke model with RPC. An Nrf2 DNA binding ELISA and protein analysis via Western blotting of downstream Nrf2 targets were performed to determine RPC-induced activation of Nrf2 in rat and mouse astrocytes. After RPC, mitochondrial function was determined by measuring reactive oxygen species production and mitochondrial respiration in both wild-type and Nrf2-/- mice. Infarct volume was measured to determine neuroprotection, whereas protein levels were measured by immunoblotting. RESULTS: We report that Nrf2 is activated by RPC in rodent astrocyte cultures, and that loss of Nrf2 reduced RPC-mediated neuroprotection in a mouse model of focal cerebral ischemia. In addition, we observed that wild-type and Nrf2-/- cortical mitochondria exhibited increased uncoupling and reactive oxygen species production after RPC treatments. Finally, Nrf2-/- astrocytes exhibited decreased mitochondrial antioxidant expression and were unable to upregulate cellular antioxidants after RPC treatment. CONCLUSIONS:Nrf2 contributes to RPC-induced neuroprotection through maintaining mitochondrial coupling and antioxidant protein expression.
Authors: Kunjan R Dave; Christian Lange-Asschenfeldt; Ami P Raval; Ricardo Prado; Raul Busto; Isabel Saul; Miguel A Pérez-Pinzón Journal: J Neurosci Res Date: 2005-12-01 Impact factor: 4.164
Authors: Hu Yan; Yao Jihong; Zhang Feng; Xu Xiaomei; Zhai Xiaohan; Wang Guangzhi; Ma Zhenhai; Gao Dongyan; Ma Xiaochi; Fan Qing; Liu Kexin; Tian Xiaofeng Journal: Crit Care Med Date: 2014-05 Impact factor: 7.598
Authors: Karen F S Bell; Jill H Fowler; Bashayer Al-Mubarak; Karen Horsburgh; Giles E Hardingham Journal: Oxid Med Cell Longev Date: 2011-06-28 Impact factor: 6.543
Authors: Kira M Holmström; Liam Baird; Ying Zhang; Iain Hargreaves; Annapurna Chalasani; John M Land; Lee Stanyer; Masayuki Yamamoto; Albena T Dinkova-Kostova; Andrey Y Abramov Journal: Biol Open Date: 2013-06-20 Impact factor: 2.422
Authors: Elga Esposito; Kazuhide Hayakawa; Bum Ju Ahn; Su Jing Chan; Changhong Xing; Anna C Liang; Kyu-Won Kim; Ken Arai; Eng H Lo Journal: J Neurochem Date: 2018-05-16 Impact factor: 5.372
Authors: Chandra K Singh; Gagan Chhabra; Mary Ann Ndiaye; Liz Mariely Garcia-Peterson; Nicholas J Mack; Nihal Ahmad Journal: Antioxid Redox Signal Date: 2017-10-20 Impact factor: 8.401